Agenus Inc. Amends 8-K Filing on Officer and Director Changes
Ticker: AGEN · Form: 8-K/A · Filed: Nov 8, 2024 · CIK: 1098972
Sentiment: neutral
Topics: amendment, corporate-governance, officer-changes, director-changes
TL;DR
Agenus Inc. is filing an amendment to its 8-K, updating info on who's running the show and how they're getting paid.
AI Summary
Agenus Inc. filed an 8-K/A on November 8, 2024, to amend a previous filing regarding events that occurred on August 8, 2024. The amendment pertains to the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements for certain officers. The company, formerly known as Antigenics Inc. /DE/, is incorporated in Delaware and headquartered in Lexington, Massachusetts.
Why It Matters
This amendment clarifies and potentially corrects information related to the company's leadership and executive compensation, which are critical for understanding corporate governance and financial health.
Risk Assessment
Risk Level: low — This is an amendment to a previous filing, primarily for clarification or correction, and does not appear to introduce new material risks.
Key Numbers
- 000-29089 — SEC File Number (Identifies the company's filing history with the SEC.)
- 06-1562417 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Agenus Inc. (company) — Registrant
- Antigenics Inc. /DE/ (company) — Former company name
- August 08, 2024 (date) — Date of earliest event reported
- November 8, 2024 (date) — Filing date
- 3 Forbes Road, Lexington, Massachusetts 02421 (location) — Principal executive offices address
FAQ
What specific information is being amended in the 8-K filing?
The 8-K/A amends information related to the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.
What was Agenus Inc.'s former name?
Agenus Inc.'s former name was Antigenics Inc. /DE/.
On what date was the earliest event reported in the original filing?
The earliest event reported in the original filing was on August 08, 2024.
Where are Agenus Inc.'s principal executive offices located?
Agenus Inc.'s principal executive offices are located at 3 Forbes Road, Lexington, Massachusetts 02421.
What is the SEC file number for Agenus Inc.?
The SEC file number for Agenus Inc. is 000-29089.
Filing Stats: 476 words · 2 min read · ~2 pages · Grade level 11.5 · Accepted 2024-11-08 16:05:08
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value per share AGEN The Nasdaq
Filing Documents
- agen-20240808.htm (8-K/A) — 36KB
- 0000950170-24-124055.txt ( ) — 146KB
- agen-20240808.xsd (EX-101.SCH) — 24KB
- agen-20240808_htm.xml (XML) — 5KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: November 8, 2024 By: /s/ Christine M. Klaskin Christine M. Klaskin, VP Finance